Literature DB >> 17448932

Chikungunya epidemic in India: a major public-health disaster.

Dileep Mavalankar, Priya Shastri, Parvathy Raman.   

Abstract

Mesh：

Year:  2007        PMID： 17448932     DOI： 10.1016/S1473-3099(07)70091-9

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  62 in total

1.  Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages.

Authors:  Karine Labadie; Thibaut Larcher; Christophe Joubert; Abdelkrim Mannioui; Benoit Delache; Patricia Brochard; Lydie Guigand; Laurence Dubreil; Pierre Lebon; Bernard Verrier; Xavier de Lamballerie; Andreas Suhrbier; Yan Cherel; Roger Le Grand; Pierre Roques
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

2.  Genome-Wide Screening Uncovers the Significance of N-Sulfation of Heparan Sulfate as a Host Cell Factor for Chikungunya Virus Infection.

Authors:  Atsushi Tanaka; Uranan Tumkosit; Shota Nakamura; Daisuke Motooka; Natsuko Kishishita; Thongkoon Priengprom; Areerat Sa-Ngasang; Taroh Kinoshita; Naokazu Takeda; Yusuke Maeda
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

3.  Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model.

Authors:  Haiyan Chu; Subash C Das; Jeremy F Fuchs; M Suresh; Scott C Weaver; Dan T Stinchcomb; Charalambos D Partidos; Jorge E Osorio
Journal:  Vaccine       Date:  2013-05-29       Impact factor: 3.641

4.  A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.

Authors:  Juan García-Arriaza; Victoria Cepeda; David Hallengärd; Carlos Óscar S Sorzano; Beate Mareike Kümmerer; Peter Liljeström; Mariano Esteban
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

5.  A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence.

Authors:  Thomas E Morrison; Lauren Oko; Stephanie A Montgomery; Alan C Whitmore; Alina R Lotstein; Bronwyn M Gunn; Susan A Elmore; Mark T Heise
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

6.  Chikungunya Outbreaks in India: A Prospective Study Comparing Neutralization and Sequelae during Two Outbreaks in 2010 and 2016.

Authors:  Jaspreet Jain; Navjot Kaur; Sherry L Haller; Ankit Kumar; Shannan L Rossi; Vimal Narayanan; Dilip Kumar; Rajni Gaind; Scott C Weaver; Albert J Auguste; Sujatha Sunil
Journal:  Am J Trop Med Hyg       Date:  2020-04       Impact factor: 2.345

7.  Epidemiology, clinical manifestations, and diagnosis of Chikungunya fever: lessons learned from the re-emerging epidemic.

Authors:  Alladi Mohan; D H N Kiran; I Chiranjeevi Manohar; D Prabath Kumar
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

8.  Persisting mixed cryoglobulinemia in Chikungunya infection.

Authors:  Manuela Oliver; Marc Grandadam; Catherine Marimoutou; Christophe Rogier; Elisabeth Botelho-Nevers; Hugues Tolou; Jean-Luc Moalic; Philippe Kraemer; Marc Morillon; Jean-Jacques Morand; Pierre Jeandel; Philippe Parola; Fabrice Simon
Journal:  PLoS Negl Trop Dis       Date:  2009-02-03

9.  Expression and evaluation of Chikungunya virus E1 and E2 envelope proteins for serodiagnosis of Chikungunya virus infection.

Authors:  Byungki Cho; Bo-Young Jeon; Jungho Kim; Jaesang Noh; Jiha Kim; Minjung Park; Sun Park
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

Review 10.  Global public health security.

Authors:  Guénaël Rodier; Allison L Greenspan; James M Hughes; David L Heymann
Journal:  Emerg Infect Dis       Date:  2007-10       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.